Filtering
- Betamethasone Valerate
- Betamethasone valerate
- Betamethasone valerate 0.1% cream
- Betamethasone-Calcipotriene Topical
- Betanis
- Betaseron
- Betaseron (Interferon beta-1b, BAY86-5046)
- Betaxolol
- Bethanechol
- Betnesol®-V Creme, 0.1%
- Betrixaban
- Bevacizumab
- Bevacizumab (Avastin)
- Bevacizumab (Avastin®)
- Bevacizumab (avastin)
- Bevacizumab 5 mg/kg
- Bevacizumab 7.5 mg/kg
- Bevacizumab Biosimilar
- Bevacizumab Biosimilar IBI305
- Bevacizumab Biosimilar IBI305 plus sintilimab
- Bevacizumab Injection
- Bevacizumab Injection [Avastin]
- Bevacizumab [Avastin]
- Bevacizumab and Bortezomib
- Bevacizumab and Carboplatin
- Bevacizumab and Erlotinib
- Bevacizumab injection
- Bevacizumab intravitreal injection
- Bevacizumab plus Atezolizumab
- Bevacizumab, erlotinib
- Bevacizumab, mFOLFOX, FOLFIRI
- Bevacizumab-800CW
- Bevacizumab-EU
- Bevacizumab-IRDye800CW
- Bevacizumab/Irinotecan
- Bevasiranib
- Bevirimat
- Bevirimat dimeglumine
- Bexagliflozin
- Bexagliflozin tablets, 20 mg
- Bexagliflozin tablets, placebo
- Bexarotene
- Bexarotene (targretin)
- Bexmarilimab
- Bexxar
- Bezafibrate
- Bezafibrate 200 MG
- Bezlotoxumab
- Bi-annual CDTI
- Biapenem
- Bicalutamide
- Bicalutamide 150 Mg Oral Tablet
- Bicalutamide 150 mg
- Bicalutamide 50 mg
- Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)
- Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)
- Bicalutamide, CP-675,206 (Tremelimumab)
- Bicifadine
- Bictegravir
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
- Bictegravir/emtricitabine/tenofovir alafenamide
- Bifeprunox
- Bifico
- Bifidobacterium breve
- Bifidobacterium breve BR03 and Bifidobacterium breve B632
- Bifidobacterium viable pharmaceutics
- Biguanide
- Biguanide (BG)
- Biguanides
- Biktarvy
- Biktarvy 50/200/25 Tab
- Biktarvy Tab
- Bilastine
- Bimagrumab
- Bimatoprost
- Bimatoprost 0.01%
- Bimatoprost 0.01% ophthalmic solution
- Bimatoprost 0.03%
- Bimatoprost 0.03% Ophthalmic Solution
- Bimatoprost 0.03% eye drops
- Bimatoprost 0.03% ophthalmic solution
- Bimatoprost 0.03% solution
- Bimatoprost Formulation A
- Bimatoprost Formulation B
- Bimatoprost Formulation C
- Bimatoprost Ophthalmic
- Bimatoprost SR
- Bimatoprost ophthalmic solution 0.01%
- Bimatoprost ophthalmic solution 0.03%
- Bimatoprost solution 0.03%
- Bimatoprost vehicle
- Bimatoprost vehicle solution
- Bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy)
- Bimatoprost/timolol fixed combination
- Bimekizumab
- Bimiralisib
- Bimosiamose
- Bindarit
- Binimetinib
- Binimetinib Oral Tablet
- Binimetinib Pill
- Binodenoson
- Binosto 70Mg Effervescent Tablet
- Bintrafusp Alfa
- Bintrafusp alfa
- Bintrafusp alfa (M7824)
- Bio-oss
- BioChaperone® Combo
- BioChaperone insulin lispro
- Bioceramic sealer
- Biodentine
- Biofreeze
- Bioidentical hormone (Biest)
- Biologic DMARDs
- Biological Drug
- Biologically active human fecal material, OpenBiome
- Biologics
- Biosimilar Infliximab
- Biotin
- Biperiden
- Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
- Biphasic human insulin
- Biphasic human insulin 30
- Biphasic human insulin 50
- Biphasic insulin aspart
- Biphasic insulin aspart 30
- Biphasic insulin aspart 50
- Biphasic insulin aspart 70
- Biphosphonates
- Birabresib
- Birinapant
- Birinapant (TL32711)
- Bisacodyl
- Bisacodyl 5 MG
- Bisacodyl 5 milligram
- Bisantrene
- Bismuth
- Bismuth Potassium Citrate
- Bismuth Subsalicylate
- Bismuth potassium citrate
- Bismuth quadruple therapy
- Bismuth subsalicylate
- Bismuth-Containing Quadruple Therapy
- Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
- Bisoprolol
- Bisoprolol Fumarate
- Bisoprolol Fumarate Tablet 10 mg
- Bisphosphonate
- Bisphosphonate treatment
- Bisphosphonates
- Bitopertin
- Bitopertin [RO4917838]
- Bivalirudin
- Bivatuzumab mertansine
- Bixalomer
- Black Cohosh
- Black cohosh
- Blank control
- Blank control 0mg
- Bleaching Agents
- Bleomycin
- Bleomycin PHC 15 e. (United States Pharmacopeia - USP)
- Bleomycin sulfate
- Bleselumab
- Blinatumomab
- Blisibimod
- Blonanserin
- Blood cardioplegia
- BoNT-A
- Boceprevir
- Boceprevir (BOC)
- Boceprevir (SCH 503034)
- Boceprevir placebo
- Bocidelpar
- Bococizumab (PF-04950615)
- Bococizumab (PF-04950615; RN316)
- Bococizumab (PF-04950615;RN316)
- Bolus
- Bombesin (68Ga) labeled (BAY86-7548)
- Bomedemstat
- Bone marrow mesenchymal stem cells
- Bone morphogenetic protein 7
- Boronophenylalanine-fructose complex
- Bortezomib
- Bortezomib (VELCADE)
- Bortezomib (Velcade)
- Bortezomib (drug)
- Bortezomib 1.3 mg/m2
- Bortezomib 1.6 mg/m2
- Bortezomib Injection
- Bortezomib, proteasome inhibitor; intravenous or subcutaneous
- Bortezomib/dexamethasone
- Bosentan
- Bosentan 125 mg
- Bosentan 62.5 mg
- Bosentan administration
- Bosutinib
- Bosutinib capsule
- Botensilimab
- Botox